img

Global Coagulation Factor VIIa Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Coagulation Factor VIIa Market Insights, Forecast to 2034

Recombinant activated factor VII (rFVIIa) binds to exposed tissue factor at the place of tissue and vascular injury. Thrombin generated by this process activates platelets and the coagulation cascade.
Global Coagulation Factor VIIa market is expected to reach to US$ 1230.2 million in 2024, with a positive growth of %, compared with US$ 1179.9 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Coagulation Factor VIIa industry is evaluated to reach US$ 1529.8 million in 2029. The CAGR will be 3.7% during 2024 to 2029.
Due to the COVID-19 pandemic, the global Recombinant Human Coagulation VIIa market size is estimated to be worth US$ 1180 million in 2022 and is forecast to a readjusted size of US$ 1467 million by 2028 with a CAGR of 3.7% during the forecast period 2022-2028. Market driver is mainly rising number of hemophilia patients across the world. Recombinant coagulation factors, as opposed to plasma-derived counterparts, consume a very low risk for transfer of infectious diseases and their use would eliminate the risk of infection from viruses such as the human immunodeficiency virus and hepatitis C. The advancement of recombinant coagulation factors has been a major importance in hemophilia care promising nearly complete safety of individuals from the risk of transmitted infections.
Report Covers
This report presents an overview of global Coagulation Factor VIIa market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Coagulation Factor VIIa market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Novo Nordisk
LFB SA HEMA Biologics
AryoGen Pharmed
GENERIUM
Segment by Type
Prefilled Syringe
Vial

Segment by Application


Congenital Hemophilia
Acquired Hemophilia
Other

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
UK
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Coagulation Factor VIIa plant distribution, commercial date of Coagulation Factor VIIa, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Coagulation Factor VIIa introduction, etc. Coagulation Factor VIIa Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports’s Conclusions of Coagulation Factor VIIa
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Coagulation Factor VIIa Product Introduction
1.2 Market by Type
1.2.1 Global Coagulation Factor VIIa Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Prefilled Syringe
1.2.3 Vial
1.3 Market by Application
1.3.1 Global Coagulation Factor VIIa Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Congenital Hemophilia
1.3.3 Acquired Hemophilia
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Coagulation Factor VIIa Sales Estimates and Forecasts 2018-2029
2.2 Global Coagulation Factor VIIa Revenue by Region
2.2.1 Global Coagulation Factor VIIa Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Coagulation Factor VIIa Revenue by Region (2018-2024)
2.2.3 Global Coagulation Factor VIIa Revenue by Region (2024-2029)
2.2.4 Global Coagulation Factor VIIa Revenue Market Share by Region (2018-2029)
2.3 Global Coagulation Factor VIIa Sales Estimates and Forecasts 2018-2029
2.4 Global Coagulation Factor VIIa Sales by Region
2.4.1 Global Coagulation Factor VIIa Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Coagulation Factor VIIa Sales by Region (2018-2024)
2.4.3 Global Coagulation Factor VIIa Sales by Region (2024-2029)
2.4.4 Global Coagulation Factor VIIa Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Coagulation Factor VIIa Sales by Manufacturers
3.1.1 Global Coagulation Factor VIIa Sales by Manufacturers (2018-2024)
3.1.2 Global Coagulation Factor VIIa Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Coagulation Factor VIIa in 2022
3.2 Global Coagulation Factor VIIa Revenue by Manufacturers
3.2.1 Global Coagulation Factor VIIa Revenue by Manufacturers (2018-2024)
3.2.2 Global Coagulation Factor VIIa Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Coagulation Factor VIIa Revenue in 2022
3.3 Global Key Players of Coagulation Factor VIIa, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Coagulation Factor VIIa Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Coagulation Factor VIIa Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Coagulation Factor VIIa, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Coagulation Factor VIIa, Product Offered and Application
3.8 Global Key Manufacturers of Coagulation Factor VIIa, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Coagulation Factor VIIa Sales by Type
4.1.1 Global Coagulation Factor VIIa Historical Sales by Type (2018-2024)
4.1.2 Global Coagulation Factor VIIa Forecasted Sales by Type (2024-2029)
4.1.3 Global Coagulation Factor VIIa Sales Market Share by Type (2018-2029)
4.2 Global Coagulation Factor VIIa Revenue by Type
4.2.1 Global Coagulation Factor VIIa Historical Revenue by Type (2018-2024)
4.2.2 Global Coagulation Factor VIIa Forecasted Revenue by Type (2024-2029)
4.2.3 Global Coagulation Factor VIIa Revenue Market Share by Type (2018-2029)
4.3 Global Coagulation Factor VIIa Price by Type
4.3.1 Global Coagulation Factor VIIa Price by Type (2018-2024)
4.3.2 Global Coagulation Factor VIIa Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Coagulation Factor VIIa Sales by Application
5.1.1 Global Coagulation Factor VIIa Historical Sales by Application (2018-2024)
5.1.2 Global Coagulation Factor VIIa Forecasted Sales by Application (2024-2029)
5.1.3 Global Coagulation Factor VIIa Sales Market Share by Application (2018-2029)
5.2 Global Coagulation Factor VIIa Revenue by Application
5.2.1 Global Coagulation Factor VIIa Historical Revenue by Application (2018-2024)
5.2.2 Global Coagulation Factor VIIa Forecasted Revenue by Application (2024-2029)
5.2.3 Global Coagulation Factor VIIa Revenue Market Share by Application (2018-2029)
5.3 Global Coagulation Factor VIIa Price by Application
5.3.1 Global Coagulation Factor VIIa Price by Application (2018-2024)
5.3.2 Global Coagulation Factor VIIa Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Coagulation Factor VIIa Market Size by Type
6.1.1 US & Canada Coagulation Factor VIIa Sales by Type (2018-2029)
6.1.2 US & Canada Coagulation Factor VIIa Revenue by Type (2018-2029)
6.2 US & Canada Coagulation Factor VIIa Market Size by Application
6.2.1 US & Canada Coagulation Factor VIIa Sales by Application (2018-2029)
6.2.2 US & Canada Coagulation Factor VIIa Revenue by Application (2018-2029)
6.3 US & Canada Coagulation Factor VIIa Market Size by Country
6.3.1 US & Canada Coagulation Factor VIIa Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Coagulation Factor VIIa Sales by Country (2018-2029)
6.3.3 US & Canada Coagulation Factor VIIa Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Coagulation Factor VIIa Market Size by Type
7.1.1 Europe Coagulation Factor VIIa Sales by Type (2018-2029)
7.1.2 Europe Coagulation Factor VIIa Revenue by Type (2018-2029)
7.2 Europe Coagulation Factor VIIa Market Size by Application
7.2.1 Europe Coagulation Factor VIIa Sales by Application (2018-2029)
7.2.2 Europe Coagulation Factor VIIa Revenue by Application (2018-2029)
7.3 Europe Coagulation Factor VIIa Market Size by Country
7.3.1 Europe Coagulation Factor VIIa Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Coagulation Factor VIIa Sales by Country (2018-2029)
7.3.3 Europe Coagulation Factor VIIa Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 UK
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Coagulation Factor VIIa Market Size
8.1.1 China Coagulation Factor VIIa Sales (2018-2029)
8.1.2 China Coagulation Factor VIIa Revenue (2018-2029)
8.2 China Coagulation Factor VIIa Market Size by Application
8.2.1 China Coagulation Factor VIIa Sales by Application (2018-2029)
8.2.2 China Coagulation Factor VIIa Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Coagulation Factor VIIa Market Size by Type
9.1.1 Asia Coagulation Factor VIIa Sales by Type (2018-2029)
9.1.2 Asia Coagulation Factor VIIa Revenue by Type (2018-2029)
9.2 Asia Coagulation Factor VIIa Market Size by Application
9.2.1 Asia Coagulation Factor VIIa Sales by Application (2018-2029)
9.2.2 Asia Coagulation Factor VIIa Revenue by Application (2018-2029)
9.3 Asia Coagulation Factor VIIa Sales by Region
9.3.1 Asia Coagulation Factor VIIa Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Coagulation Factor VIIa Revenue by Region (2018-2029)
9.3.3 Asia Coagulation Factor VIIa Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Coagulation Factor VIIa Market Size by Type
10.1.1 Middle East, Africa and Latin America Coagulation Factor VIIa Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Coagulation Factor VIIa Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Coagulation Factor VIIa Market Size by Application
10.2.1 Middle East, Africa and Latin America Coagulation Factor VIIa Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Coagulation Factor VIIa Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Coagulation Factor VIIa Sales by Country
10.3.1 Middle East, Africa and Latin America Coagulation Factor VIIa Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Coagulation Factor VIIa Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Coagulation Factor VIIa Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Novo Nordisk
11.1.1 Novo Nordisk Company Information
11.1.2 Novo Nordisk Overview
11.1.3 Novo Nordisk Coagulation Factor VIIa Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Novo Nordisk Coagulation Factor VIIa Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Novo Nordisk Recent Developments
11.2 LFB SA HEMA Biologics
11.2.1 LFB SA HEMA Biologics Company Information
11.2.2 LFB SA HEMA Biologics Overview
11.2.3 LFB SA HEMA Biologics Coagulation Factor VIIa Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 LFB SA HEMA Biologics Coagulation Factor VIIa Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 LFB SA HEMA Biologics Recent Developments
11.3 AryoGen Pharmed
11.3.1 AryoGen Pharmed Company Information
11.3.2 AryoGen Pharmed Overview
11.3.3 AryoGen Pharmed Coagulation Factor VIIa Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 AryoGen Pharmed Coagulation Factor VIIa Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 AryoGen Pharmed Recent Developments
11.4 GENERIUM
11.4.1 GENERIUM Company Information
11.4.2 GENERIUM Overview
11.4.3 GENERIUM Coagulation Factor VIIa Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 GENERIUM Coagulation Factor VIIa Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 GENERIUM Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Coagulation Factor VIIa Industry Chain Analysis
12.2 Coagulation Factor VIIa Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Coagulation Factor VIIa Production Mode & Process
12.4 Coagulation Factor VIIa Sales and Marketing
12.4.1 Coagulation Factor VIIa Sales Channels
12.4.2 Coagulation Factor VIIa Distributors
12.5 Coagulation Factor VIIa Customers
13 Market Dynamics
13.1 Coagulation Factor VIIa Industry Trends
13.2 Coagulation Factor VIIa Market Drivers
13.3 Coagulation Factor VIIa Market Challenges
13.4 Coagulation Factor VIIa Market Restraints
14 Key Findings in The Global Coagulation Factor VIIa Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Coagulation Factor VIIa Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Prefilled Syringe
Table 3. Major Manufacturers of Vial
Table 4. Global Coagulation Factor VIIa Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Coagulation Factor VIIa Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Coagulation Factor VIIa Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Coagulation Factor VIIa Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Coagulation Factor VIIa Revenue Market Share by Region (2018-2024)
Table 9. Global Coagulation Factor VIIa Revenue Market Share by Region (2024-2029)
Table 10. Global Coagulation Factor VIIa Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Coagulation Factor VIIa Sales by Region (2018-2024) & (MT)
Table 12. Global Coagulation Factor VIIa Sales by Region (2024-2029) & (MT)
Table 13. Global Coagulation Factor VIIa Sales Market Share by Region (2018-2024)
Table 14. Global Coagulation Factor VIIa Sales Market Share by Region (2024-2029)
Table 15. Global Coagulation Factor VIIa Sales by Manufacturers (2018-2024) & (MT)
Table 16. Global Coagulation Factor VIIa Sales Share by Manufacturers (2018-2024)
Table 17. Global Coagulation Factor VIIa Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Coagulation Factor VIIa Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Coagulation Factor VIIa, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Coagulation Factor VIIa Price by Manufacturers 2018-2024 (USD/Kg)
Table 21. Global Coagulation Factor VIIa Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Coagulation Factor VIIa by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Coagulation Factor VIIa as of 2022)
Table 23. Global Key Manufacturers of Coagulation Factor VIIa, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Coagulation Factor VIIa, Product Offered and Application
Table 25. Global Key Manufacturers of Coagulation Factor VIIa, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Coagulation Factor VIIa Sales by Type (2018-2024) & (MT)
Table 28. Global Coagulation Factor VIIa Sales by Type (2024-2029) & (MT)
Table 29. Global Coagulation Factor VIIa Sales Share by Type (2018-2024)
Table 30. Global Coagulation Factor VIIa Sales Share by Type (2024-2029)
Table 31. Global Coagulation Factor VIIa Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Coagulation Factor VIIa Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Coagulation Factor VIIa Revenue Share by Type (2018-2024)
Table 34. Global Coagulation Factor VIIa Revenue Share by Type (2024-2029)
Table 35. Coagulation Factor VIIa Price by Type (2018-2024) & (USD/Kg)
Table 36. Global Coagulation Factor VIIa Price Forecast by Type (2024-2029) & (USD/Kg)
Table 37. Global Coagulation Factor VIIa Sales by Application (2018-2024) & (MT)
Table 38. Global Coagulation Factor VIIa Sales by Application (2024-2029) & (MT)
Table 39. Global Coagulation Factor VIIa Sales Share by Application (2018-2024)
Table 40. Global Coagulation Factor VIIa Sales Share by Application (2024-2029)
Table 41. Global Coagulation Factor VIIa Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Coagulation Factor VIIa Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Coagulation Factor VIIa Revenue Share by Application (2018-2024)
Table 44. Global Coagulation Factor VIIa Revenue Share by Application (2024-2029)
Table 45. Coagulation Factor VIIa Price by Application (2018-2024) & (USD/Kg)
Table 46. Global Coagulation Factor VIIa Price Forecast by Application (2024-2029) & (USD/Kg)
Table 47. US & Canada Coagulation Factor VIIa Sales by Type (2018-2024) & (MT)
Table 48. US & Canada Coagulation Factor VIIa Sales by Type (2024-2029) & (MT)
Table 49. US & Canada Coagulation Factor VIIa Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Coagulation Factor VIIa Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Coagulation Factor VIIa Sales by Application (2018-2024) & (MT)
Table 52. US & Canada Coagulation Factor VIIa Sales by Application (2024-2029) & (MT)
Table 53. US & Canada Coagulation Factor VIIa Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Coagulation Factor VIIa Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Coagulation Factor VIIa Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Coagulation Factor VIIa Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Coagulation Factor VIIa Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Coagulation Factor VIIa Sales by Country (2018-2024) & (MT)
Table 59. US & Canada Coagulation Factor VIIa Sales by Country (2024-2029) & (MT)
Table 60. Europe Coagulation Factor VIIa Sales by Type (2018-2024) & (MT)
Table 61. Europe Coagulation Factor VIIa Sales by Type (2024-2029) & (MT)
Table 62. Europe Coagulation Factor VIIa Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Coagulation Factor VIIa Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Coagulation Factor VIIa Sales by Application (2018-2024) & (MT)
Table 65. Europe Coagulation Factor VIIa Sales by Application (2024-2029) & (MT)
Table 66. Europe Coagulation Factor VIIa Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Coagulation Factor VIIa Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Coagulation Factor VIIa Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Coagulation Factor VIIa Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Coagulation Factor VIIa Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Coagulation Factor VIIa Sales by Country (2018-2024) & (MT)
Table 72. Europe Coagulation Factor VIIa Sales by Country (2024-2029) & (MT)
Table 73. China Coagulation Factor VIIa Sales by Type (2018-2024) & (MT)
Table 74. China Coagulation Factor VIIa Sales by Type (2024-2029) & (MT)
Table 75. China Coagulation Factor VIIa Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Coagulation Factor VIIa Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Coagulation Factor VIIa Sales by Application (2018-2024) & (MT)
Table 78. China Coagulation Factor VIIa Sales by Application (2024-2029) & (MT)
Table 79. China Coagulation Factor VIIa Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Coagulation Factor VIIa Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Coagulation Factor VIIa Sales by Type (2018-2024) & (MT)
Table 82. Asia Coagulation Factor VIIa Sales by Type (2024-2029) & (MT)
Table 83. Asia Coagulation Factor VIIa Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Coagulation Factor VIIa Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Coagulation Factor VIIa Sales by Application (2018-2024) & (MT)
Table 86. Asia Coagulation Factor VIIa Sales by Application (2024-2029) & (MT)
Table 87. Asia Coagulation Factor VIIa Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Coagulation Factor VIIa Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Coagulation Factor VIIa Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Coagulation Factor VIIa Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Coagulation Factor VIIa Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Coagulation Factor VIIa Sales by Region (2018-2024) & (MT)
Table 93. Asia Coagulation Factor VIIa Sales by Region (2024-2029) & (MT)
Table 94. Middle East, Africa and Latin America Coagulation Factor VIIa Sales by Type (2018-2024) & (MT)
Table 95. Middle East, Africa and Latin America Coagulation Factor VIIa Sales by Type (2024-2029) & (MT)
Table 96. Middle East, Africa and Latin America Coagulation Factor VIIa Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Coagulation Factor VIIa Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Coagulation Factor VIIa Sales by Application (2018-2024) & (MT)
Table 99. Middle East, Africa and Latin America Coagulation Factor VIIa Sales by Application (2024-2029) & (MT)
Table 100. Middle East, Africa and Latin America Coagulation Factor VIIa Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Coagulation Factor VIIa Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Coagulation Factor VIIa Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Coagulation Factor VIIa Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Coagulation Factor VIIa Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Coagulation Factor VIIa Sales by Country (2018-2024) & (MT)
Table 106. Middle East, Africa and Latin America Coagulation Factor VIIa Sales by Country (2024-2029) & (MT)
Table 107. Novo Nordisk Company Information
Table 108. Novo Nordisk Description and Major Businesses
Table 109. Novo Nordisk Coagulation Factor VIIa Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2024)
Table 110. Novo Nordisk Coagulation Factor VIIa Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Novo Nordisk Recent Developments
Table 112. LFB SA HEMA Biologics Company Information
Table 113. LFB SA HEMA Biologics Description and Major Businesses
Table 114. LFB SA HEMA Biologics Coagulation Factor VIIa Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2024)
Table 115. LFB SA HEMA Biologics Coagulation Factor VIIa Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. LFB SA HEMA Biologics Recent Developments
Table 117. AryoGen Pharmed Company Information
Table 118. AryoGen Pharmed Description and Major Businesses
Table 119. AryoGen Pharmed Coagulation Factor VIIa Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2024)
Table 120. AryoGen Pharmed Coagulation Factor VIIa Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. AryoGen Pharmed Recent Developments
Table 122. GENERIUM Company Information
Table 123. GENERIUM Description and Major Businesses
Table 124. GENERIUM Coagulation Factor VIIa Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2024)
Table 125. GENERIUM Coagulation Factor VIIa Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. GENERIUM Recent Developments
Table 127. Key Raw Materials Lists
Table 128. Raw Materials Key Suppliers Lists
Table 129. Coagulation Factor VIIa Distributors List
Table 130. Coagulation Factor VIIa Customers List
Table 131. Coagulation Factor VIIa Market Trends
Table 132. Coagulation Factor VIIa Market Drivers
Table 133. Coagulation Factor VIIa Market Challenges
Table 134. Coagulation Factor VIIa Market Restraints
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
List of Figures
Figure 1. Coagulation Factor VIIa Product Picture
Figure 2. Global Coagulation Factor VIIa Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Coagulation Factor VIIa Market Share by Type in 2022 & 2029
Figure 4. Prefilled Syringe Product Picture
Figure 5. Vial Product Picture
Figure 6. Global Coagulation Factor VIIa Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Coagulation Factor VIIa Market Share by Application in 2022 & 2029
Figure 8. Congenital Hemophilia
Figure 9. Acquired Hemophilia
Figure 10. Other
Figure 11. Coagulation Factor VIIa Report Years Considered
Figure 12. Global Coagulation Factor VIIa Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Coagulation Factor VIIa Revenue 2018-2029 (US$ Million)
Figure 14. Global Coagulation Factor VIIa Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 15. Global Coagulation Factor VIIa Revenue Market Share by Region (2018-2029)
Figure 16. Global Coagulation Factor VIIa Sales 2018-2029 ((MT)
Figure 17. Global Coagulation Factor VIIa Sales Market Share by Region (2018-2029)
Figure 18. US & Canada Coagulation Factor VIIa Sales YoY (2018-2029) & (MT)
Figure 19. US & Canada Coagulation Factor VIIa Revenue YoY (2018-2029) & (US$ Million)
Figure 20. Europe Coagulation Factor VIIa Sales YoY (2018-2029) & (MT)
Figure 21. Europe Coagulation Factor VIIa Revenue YoY (2018-2029) & (US$ Million)
Figure 22. China Coagulation Factor VIIa Sales YoY (2018-2029) & (MT)
Figure 23. China Coagulation Factor VIIa Revenue YoY (2018-2029) & (US$ Million)
Figure 24. Asia (excluding China) Coagulation Factor VIIa Sales YoY (2018-2029) & (MT)
Figure 25. Asia (excluding China) Coagulation Factor VIIa Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Middle East, Africa and Latin America Coagulation Factor VIIa Sales YoY (2018-2029) & (MT)
Figure 27. Middle East, Africa and Latin America Coagulation Factor VIIa Revenue YoY (2018-2029) & (US$ Million)
Figure 28. The Coagulation Factor VIIa Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 29. The Top 5 and 10 Largest Manufacturers of Coagulation Factor VIIa in the World: Market Share by Coagulation Factor VIIa Revenue in 2022
Figure 30. Global Coagulation Factor VIIa Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 31. Global Coagulation Factor VIIa Sales Market Share by Type (2018-2029)
Figure 32. Global Coagulation Factor VIIa Revenue Market Share by Type (2018-2029)
Figure 33. Global Coagulation Factor VIIa Sales Market Share by Application (2018-2029)
Figure 34. Global Coagulation Factor VIIa Revenue Market Share by Application (2018-2029)
Figure 35. US & Canada Coagulation Factor VIIa Sales Market Share by Type (2018-2029)
Figure 36. US & Canada Coagulation Factor VIIa Revenue Market Share by Type (2018-2029)
Figure 37. US & Canada Coagulation Factor VIIa Sales Market Share by Application (2018-2029)
Figure 38. US & Canada Coagulation Factor VIIa Revenue Market Share by Application (2018-2029)
Figure 39. US & Canada Coagulation Factor VIIa Revenue Share by Country (2018-2029)
Figure 40. US & Canada Coagulation Factor VIIa Sales Share by Country (2018-2029)
Figure 41. U.S. Coagulation Factor VIIa Revenue (2018-2029) & (US$ Million)
Figure 42. Canada Coagulation Factor VIIa Revenue (2018-2029) & (US$ Million)
Figure 43. Mexico Coagulation Factor VIIa Revenue (2018-2029) & (US$ Million)
Figure 44. Europe Coagulation Factor VIIa Sales Market Share by Type (2018-2029)
Figure 45. Europe Coagulation Factor VIIa Revenue Market Share by Type (2018-2029)
Figure 46. Europe Coagulation Factor VIIa Sales Market Share by Application (2018-2029)
Figure 47. Europe Coagulation Factor VIIa Revenue Market Share by Application (2018-2029)
Figure 48. Europe Coagulation Factor VIIa Revenue Share by Country (2018-2029)
Figure 49. Europe Coagulation Factor VIIa Sales Share by Country (2018-2029)
Figure 50. Germany Coagulation Factor VIIa Revenue (2018-2029) & (US$ Million)
Figure 51. France Coagulation Factor VIIa Revenue (2018-2029) & (US$ Million)
Figure 52. UK Coagulation Factor VIIa Revenue (2018-2029) & (US$ Million)
Figure 53. Italy Coagulation Factor VIIa Revenue (2018-2029) & (US$ Million)
Figure 54. Russia Coagulation Factor VIIa Revenue (2018-2029) & (US$ Million)
Figure 55. China Coagulation Factor VIIa Sales Market Share by Type (2018-2029)
Figure 56. China Coagulation Factor VIIa Revenue Market Share by Type (2018-2029)
Figure 57. China Coagulation Factor VIIa Sales Market Share by Application (2018-2029)
Figure 58. China Coagulation Factor VIIa Revenue Market Share by Application (2018-2029)
Figure 59. Asia Coagulation Factor VIIa Sales Market Share by Type (2018-2029)
Figure 60. Asia Coagulation Factor VIIa Revenue Market Share by Type (2018-2029)
Figure 61. Asia Coagulation Factor VIIa Sales Market Share by Application (2018-2029)
Figure 62. Asia Coagulation Factor VIIa Revenue Market Share by Application (2018-2029)
Figure 63. Asia Coagulation Factor VIIa Revenue Share by Region (2018-2029)
Figure 64. Asia Coagulation Factor VIIa Sales Share by Region (2018-2029)
Figure 65. Japan Coagulation Factor VIIa Revenue (2018-2029) & (US$ Million)
Figure 66. South Korea Coagulation Factor VIIa Revenue (2018-2029) & (US$ Million)
Figure 67. China Taiwan Coagulation Factor VIIa Revenue (2018-2029) & (US$ Million)
Figure 68. Southeast Asia Coagulation Factor VIIa Revenue (2018-2029) & (US$ Million)
Figure 69. India Coagulation Factor VIIa Revenue (2018-2029) & (US$ Million)
Figure 70. Middle East, Africa and Latin America Coagulation Factor VIIa Sales Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America Coagulation Factor VIIa Revenue Market Share by Type (2018-2029)
Figure 72. Middle East, Africa and Latin America Coagulation Factor VIIa Sales Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America Coagulation Factor VIIa Revenue Market Share by Application (2018-2029)
Figure 74. Middle East, Africa and Latin America Coagulation Factor VIIa Revenue Share by Country (2018-2029)
Figure 75. Middle East, Africa and Latin America Coagulation Factor VIIa Sales Share by Country (2018-2029)
Figure 76. Brazil Coagulation Factor VIIa Revenue (2018-2029) & (US$ Million)
Figure 77. Mexico Coagulation Factor VIIa Revenue (2018-2029) & (US$ Million)
Figure 78. Turkey Coagulation Factor VIIa Revenue (2018-2029) & (US$ Million)
Figure 79. Israel Coagulation Factor VIIa Revenue (2018-2029) & (US$ Million)
Figure 80. GCC Countries Coagulation Factor VIIa Revenue (2018-2029) & (US$ Million)
Figure 81. Coagulation Factor VIIa Value Chain
Figure 82. Coagulation Factor VIIa Production Process
Figure 83. Channels of Distribution
Figure 84. Distributors Profiles
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed